Online citations, reference lists, and bibliographies.
← Back to Search

Nitric Oxide In Chronic Airway Inflammation In Children: Diagnostic Use And Pathophysiological Significance

I. Narang, R. Ersu, N. Wilson, A. Bush
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Background: The levels of exhaled and nasal nitric oxide (eNO and nNO) in groups of patients with inflammatory lung diseases are well documented but the diagnostic use of these measurements in an individual is unknown. Methods: The levels of nNO and eNO were compared in 31 children with primary ciliary dyskinesia (PCD), 21 with non-CF bronchiectasis (Bx), 17 with cystic fibrosis (CF), 35 with asthma (A), and 53 healthy controls (C) using a chemiluminescence NO analyser. A diagnostic receiver-operator characteristic (ROC) curve for PCD using NO was constructed. Results: The median (range) levels of nNO in parts per billion (ppb) in PCD, Bx, CF, and C were 60.3 (3.3–920), 533.6 (80–2053), 491.3 (31–1140), and 716 (398–1437), respectively; nNO levels were significantly lower in PCD than in all other groups (p<0.05). The median (range) levels of eNO in ppb in PCD, Bx, CF, A, and C were 2.0 (0.2–5.2), 5.4 (1.0–22.1), 2.6 (0.8–12.9), 10.7 (1.6–46.7), and 4.85 (2.5–18.3), respectively. The difference in eNO levels in PCD reached significance (p<0.05) when compared with those in Bx, A and C but not when compared with CF. Using the ROC curve, nNO of 250 ppb showed a sensitivity of 97% and a specificity of 90% for the diagnosis of PCD. Conclusions: eNO and nNO cannot be used diagnostically to distinguish between most respiratory diseases. However, nNO in particular is a quick and useful diagnostic marker which may be used to screen patients with a clinical suspicion of PCD.
This paper references
10.1034/j.1399-3003.1999.13f28.x
Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia.
B. Karadağ (1999)
10.1183/09031936.94.07081501
Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome.
J. Lundberg (1994)
10.1136/thx.48.10.1034
Nitric oxide and lung disease.
P. Barnes (1993)
10.1164/AJRCCM.151.6.7767536
Elevated levels of exhaled nitric oxide in bronchiectasis.
S. Kharitonov (1995)
10.1164/AJRCCM.162.6.2003051
Reduced nasal nitric oxide in diffuse panbronchiolitis.
H. Nakano (2000)
Primary nasal origin of exhaled nitric oxide and absence in Kartagener’s syndrome
JON Lundberg (1994)
10.1164/AJRCCM.159.1.9804134
A community study of exhaled nitric oxide in healthy children.
P. Franklin (1999)
10.1016/S0022-3476(98)70344-0
The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.
B. Rosenstein (1998)
Exhaled nitric oxide in chronic airway inflammation
10.1016/S0022-3476(97)80062-5
Corticosteroids decrease exhaled nitric oxide in children with acute asthma.
E. Baraldi (1997)
10.1002/(SICI)1099-0496(199711)24:5<312::AID-PPUL2>3.0.CO;2-K
Exhaled nitric oxide measurements in normal and asthmatic children
C. A. Byrnes (1997)
10.1136/adc.64.7.1065
Management of asthma: a consensus statement.
J. Warner (1989)
10.1136/ADC.64.12.1760
Management of asthma: a consensus statement.
S. Godfrey (1989)
10.1136/THX.52.6.540
Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath holding.
S. Kharitonov (1997)
10.1136/THX.52.8.697
Effect of measurement conditions on measured levels of peak exhaled nitric oxide.
C. A. Byrnes (1997)
10.1183/09031936.98.12040982
Primary ciliary dyskinesia: diagnosis and standards of care.
A. Bush (1998)
10.1183/09031936.97.10071683
Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.
S. Kharitonov (1997)
PCD : diagnosis and standards of care
A Bush (1998)
10.1016/S0022-3476(98)70337-3
Making the diagnosis of cystic fibrosis.
R. Wilmott (1998)
10.1136/adc.78.1.49
Nitric oxide metabolites in cystic fibrosis lung disease
H. Grasemann (1998)
10.1136/adc.75.4.319
Reduced upper airway nitric oxide in cystic fibrosis.
I. Balfour-Lynn (1996)
10.1034/j.1399-3038.2001.012003125.x
Asthma severity and inflammation markers in children
N. Wilson (2001)
Nasal contribution to exhaled nitric oxide during exhalation against resistance or during breath hold. Thorax 1997;52:540–5
SA Kharitonov (1997)
10.1006/BBRC.1993.1187
Modulation of airway epithelial cell ciliary beat frequency by nitric oxide.
B. Jain (1993)
Expression of iNOS in human lung epithelial cells
RA Robbins (1994)
10.1006/BBRC.1994.2169
Expression of inducible nitric oxide in human lung epithelial cells.
R. Robbins (1994)



This paper is referenced by
10.1164/RCCM.200506-962OC
Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma.
E. Paraskakis (2006)
10.1164/rccm.200406-710st
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.
(2005)
Management of chronic rhinosinusitis in children
ri José Antonio Sacre-Hazouri (2013)
10.1002/ppul.22577
Longitudinal lung function and structural changes in children with primary ciliary dyskinesia
Marie Magnin (2012)
10.1097/MAO.0000000000001599
Analysis of Otologic Features of Patients With Primary Ciliary Dyskinesia.
K. Takeuchi (2017)
10.1016/S0378-3782(03)00013-6
Nasal and lower airway levels of nitric oxide in prematurely born infants.
O. Williams (2003)
10.1016/S1569-1993(03)00061-4
Exhaled nitric oxide increases following admission for intravenous antibiotics in children with cystic fibrosis.
A. Jaffe (2003)
10.1371/journal.pone.0057262
Hand-Held Tidal Breathing Nasal Nitric Oxide Measurement – A Promising Targeted Case-Finding Tool for the Diagnosis of Primary Ciliary Dyskinesia
J. K. Marthin (2013)
10.1016/J.RMED.2006.12.005
Airway nitric oxide output is reduced in bronchiectasis.
S. Foley (2007)
10.1016/j.jaci.2010.06.047
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.
J. Brozek (2010)
10.1016/J.PRRV.2007.07.007
Measurement of nasal nitric oxide.
R. Corbelli (2007)
10.1016/j.prrv.2008.10.001
Primary ciliary dyskinesia: when to suspect the diagnosis and how to confirm it.
C. Hogg (2009)
10.1016/j.wjorl.2016.02.004
Normal values of nasal NO and exhaled NO in young Chinese people aged 9 – 22 years
Shaohua You (2016)
10.1136/thx.2005.056093
Exhaled nitric oxide measurements: clinical application and interpretation
D. Taylor (2006)
10.1016/J.PEDEX.2011.11.003
Primary ciliary dyskinesia in two siblings
T. Tanaka (2012)
10.1016/B978-0-12-374001-4.00065-1
Chapter 65 – Pediatric Asthma: How Early Life Events Cause Lifelong Respiratory Disease
A. Bush (2009)
10.1136/thx.2007.084228
Biomarkers in COPD: time for a deep breath
R. Stockley (2007)
VIII. Nasal NO Measurements
(2007)
10.4046/trd.2013.74.1.7
Measurement of Fractional Exhaled Nitric Oxide in Stable Bronchiectasis
Y. Cho (2013)
10.1007/s00431-012-1785-6
Primary ciliary dyskinesia, an orphan disease
M. Boon (2012)
10.1007/978-1-4939-1801-0_14
Fractional Exhaled Nitric Oxide: Indications and Interpretation
Young-Jee Kim (2015)
10.1556/OH.2010.28972
[Role of exhaled nitric oxide in predicting steroid response in chronic obstructive pulmonary disease].
B. Antus (2010)
application and interpretation Exhaled nitric oxide measurements: clinical
D. Taylor (2006)
Diagnosing primary ciliary dyskinesia: a nationally funded diagnostic service should lead to improved outcome
C. O'callaghan (2007)
10.1183/23120541.00231-2018
Spirometric indices in primary ciliary dyskinesia: systematic review and meta-analysis
Florian S. Halbeisen (2019)
10.1016/j.ijporl.2010.03.025
Nasal nitric oxide in children with adenoidal hypertrophy: a preliminary study.
S. Torretta (2010)
10.1136/thx.2009.126912
Prediction of asthma in symptomatic preschool children using exhaled nitric oxide, Rint and specific IgE
D. Caudri (2010)
10.1002/PPUL.20670
Nitric oxide production in PCD: Possible evidence for differential nitric oxide synthase function
E. Paraskakis (2007)
10.1164/rccm.200303-365oc
Primary ciliary dyskinesia: diagnostic and phenotypic features.
P. Noone (2004)
10.1089/PED.2013.0314
Primary Ciliary Dyskinesia: An Update on New Diagnostic Modalities and Review of the Literature.
Rizwana Popatia (2014)
10.1513/AnnalsATS.201305-110OC
Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia.
M. Leigh (2013)
10.3892/mmr.2016.5871
Whole-exome sequencing identification of novel DNAH5 mutations in a young patient with primary ciliary dyskinesia
G. Kano (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar